Cuiling Zeng
State Key Laboratory Of Oncology In South China, 651 Dongfeng Road East
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Correction: The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 27, 2026
ASB7 promotes osteosarcoma lung metastasis through ubiquitin-mediated degradation of ATF2.
Journal: Cell discovery
Published: October 13, 2025
PIM3-mediated phosphorylation stabilizes myeloid leukemia factor 2 to promote metastasis in osteosarcoma.
Journal: The Journal of clinical investigation
Published: January 07, 2025
The KLF16/MYC feedback loop is a therapeutic target in bladder cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 14, 2024
Targeting RBM39 suppresses tumor growth and sensitizes osteosarcoma cells to cisplatin.
Journal: Oncogene
Published: May 16, 2024
Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
Journal: Nature cell biology
Published: February 05, 2024
Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 23, 2023
Augmenting L3MBTL2-induced condensates suppresses tumor growth in osteosarcoma.
Journal: Science advances
Published: November 22, 2023
Targeting the Lysosomal Degradation of Rab22a-NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis.
Targeting the Lysosomal Degradation of Rab22a-NeoF1 Fusion Protein for Osteosarcoma Lung Metastasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 21, 2022
Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes.
Journal: Signal transduction and targeted therapy
Published: June 30, 2020
Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
Journal: Nature cell biology
Published: June 13, 2020
Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma.
Journal: Nature cell biology
Published: January 17, 2019
Last Updated: 09/26/2026